U.S. FDA panel backs Abbott stent that dissolves in the body
(Reuters) - A medical advisory panel to the U.S. Food and Drug Administration on Tuesday recommended approval of a first-of-its-kind heart stent from Abbott Laboratories that dissolves after it is implanted.
Aucun commentaire:
Enregistrer un commentaire